Lymphoma Management in North Carolina: Updates for 2023
![](https://learn.unclcn.org/sites/default/files/styles/course_image_teaser/public/course/2023-01/Grover%20R2P%20CI%20140px.jpg?itok=NCWPhln_)
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
Category
- Research to Practice
Format
- Self-Paced, Online Courses
Credits
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR Category A
- 1.00 NCPD/CNE
- 1.00 Participation